NCT03057470 - Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

50% bolus insulin correction

Patients will receive 50% of their usual bolus insulin correction for post-exercise hyperglycemia

DRUG

100% bolus insulin correction

Patients will receive 100% of their usual bolus insulin correction for post-exercise hyperglycemia

DRUG

150% bolus insulin correction

Patients will receive 150% of their usual bolus insulin correction for post-exercise hyperglycemia

OTHER

0% bolus insulin correction

Patients will receive no bolus insulin correction for post-exercise hyperglycemia

Trial Locations (1)

RECRUITING

LMC Bayview, Toronto